Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Do you really want to delete this prezi?
Neither you, nor the coeditors you shared it with will be able to recover it again.
Make your likes visible on Facebook?
You can change this under Settings & Account at any time.
Business Plan of Epidermal Glucose Monitor - Team 7
Transcript of Business Plan of Epidermal Glucose Monitor - Team 7
We are going to integrate an epidermal and noninvasive diabetes testing device that can be stick to human skin and easily to remove. It is disposable and looks like a thin plastic paper, which is about 12cm2, embedded with mental circuits that can be slightly bended or squeezed.
Customer Segmentation By Age & Region
Customer Segmentation By Income
"Me" Consumers from upper-middle and high income: 152.8 Million Cases
"Desperate" Consumer usually over 65
years old: 4.6 Million Cases
Near infrared LED based non-invasive blood glucose
Near Infrared Technology Advantage
Near Field Communication based data access method
Product Road Map (Months-Stages)
Epidermal electronic system
Memory size 2k byte
Maxim speed 106kb/s
$0.1 each piece
Using mobile handset
Financial and Funding Plan
Sales and Market Strategy
Epidermal- Continuous detecting prevent patient from sudden death due to hypoglycemia.
Non-invasive-No blood involved decreases the chance of infection
NFC- Save cost due to display free
We define our IP as a patent combining three technologies
Distributor Partner: Abbott Diabetes Care
Why Abbott: Development Strategy Match
Mature Sales Channel
Experienced FDA Team
Abbott Diabetes Care
Branch of Abbott
Medical Products Expert
Sales Volume Over Time
Cited from Epidermal Electronics, D. H. Kim et al., Science 333, 838-843 (2011).
Cite from: Yadav J, Rani A, Singh V, et al. Near-infrared LED based non-invasive blood glucose sensor[C]//Signal Processing and Integrated Networks (SPIN), 2014 International Conference on. IEEE, 2014: 591-594.
Test strip: $4 for 4 times per day
Meter: $15 (Negligible)
Our device: $2 for 48 times per day
Our cost :$1
Continuous Glucose Monitor
Drugs in development in the U.S.
3.4 Million Death
Linear V-BG relationship
Our motion is to provide convenient and continuous glucose monitoring for diabetes, in order to give patients a better understanding of their glucose levels related with treatment, diets, and activities.
2 pieces each customer per month
15% of Chinese market at the end of year 5
(98 million x 10% target customer x 6 pieces per quarter x 15% of the market= 9 million)
Annual Revenue for 5 Years
Profit & Loss Statement
Largest dedicate investment
We are seeking for $500k angel investment as start-up and $15MM VC investment. Our year 5 revenue is $71MM, giving 6.6x ROI and 60% IRR.
2. CTO: building R&D team to transfer EES into applications and manufacturing
3. Adviser Board
Professor: Technical adviser
Medical Doctor: experiences in diabetes treatment who can suggest opinion for epidermal testing
4. Strategic Partner: Abbott Diabetes Care
1. Epidermal Electronic technology: We buy license from University of Illinois
2. Infrared detecting system: Design by us
3. NFC: Buy components
Technology from the Rogers Research group at The University of Illinois at Urbana–Champaign